Showing results (241-250 of 452) with videos related to
Sort By:
Pageof 46
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
The so-called stunning of thyroid tissueJames C Sisson, Anca M Avram, Susan A Lawson, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient studyYuni K Dewaraja, Scott J Wilderman, Kenneth F Koral, et al.Clinical Nuclear Medicine|July 18, 2018
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid CancerPoorni M Manohar, Lauren J Beesley, Emily L Bellile, et al.Dermatologic Therapy|February 1, 2011
Laser hair removalOmar A Ibrahimi, Mathew M Avram, C William Hanke, et al.Chirurgia (Bucharest, Romania : 1990)|October 15, 2010
[Laparoscopic approach in gallbladder agenesis--an intraoperative surprise]M Beuran, S Păun, I Negoi, et al.Thyroid : Official Journal of the American Thyroid Association|July 10, 2004
Cryptococcal thyroiditis and hyperthyroidismAnca M Avram, Christine A Sturm, Claire W Michael, et al.Thyroid : Official Journal of the American Thyroid Association|February 12, 2009
Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodineJames C Sisson, Yuni K Dewaraja, Eric J Wizauer, et al.Clinical Nuclear Medicine|March 22, 2006
Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotideAnca M Avram, Gavin C Mackie, Bryan J Schneider, et al.AJR. American Journal of Roentgenology|August 24, 2010
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CTKa Kit Wong, James C Sisson, Kenneth F Koral, et al.Cancer Biotherapy & Radiopharmaceuticals|September 6, 2012
Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activityMatthew J Schipper, Kenneth F Koral, Anca M Avram, et al.Pageof 46